{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T17:30:45Z","timestamp":1648920645578},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Semin Surg Oncol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1186\/1477-7800-2-12","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T06:13:34Z","timestamp":1117606414000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Durable remissions are rare following high dose therapy with autologous stem cell transplantation for adults with \"paediatric\" bone and soft tissue sarcomas"],"prefix":"10.1186","volume":"2","author":[{"given":"Shriram V","family":"Nath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H Miles","family":"Prince","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter FM","family":"Choong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy C","family":"Toner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,5,31]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/00001622-200403000-00006","volume":"16","author":"PA Meyers","year":"2004","unstructured":"Meyers PA: High dose therapy with autologous stem cell rescue for pediatric sarcomas. Curr Opin Oncol. 2004, 16: 120-125. 10.1097\/00001622-200403000-00006.","journal-title":"Curr Opin Oncol"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1040-8428(01)00153-6","volume":"41","author":"P Reichardt","year":"2002","unstructured":"Reichardt P: High-dose chemotherapy in adult soft tissue sarcoma. Critical Reviews in Oncology\/Hematology. 2002, 41: 157-167. 10.1016\/S1040-8428(01)00153-6.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/13577140310001607266","volume":"7","author":"VH Bramwell","year":"2003","unstructured":"Bramwell VH: Management of advanced adult soft tissue sarcoma. Sarcoma. 2003, 7: 43-55. 10.1080\/13577140310001607266.","journal-title":"Sarcoma"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/annonc\/mdg335","volume":"14","author":"G Saeter","year":"2003","unstructured":"Saeter G, ESMO: Minimum clinical recommendations for diagnosis, treatment and follow-up of Ewing's sarcoma of bone. Ann Oncol. 2003, 14: 1167-1168. 10.1093\/annonc\/mdg335.","journal-title":"Ann Oncol"},{"key":"15_CR5","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1200\/JCO.1997.15.7.2611","volume":"15","author":"MW Verrill","year":"1997","unstructured":"Verrill MW, Judson IR, Harmer CL, et al: Ewing's sarcoma andprimitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children?. J Clin Oncol. 1997, 15: 2611-2621.","journal-title":"J Clin Oncol"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1056\/NEJMoa020890","volume":"348","author":"HE Grier","year":"2003","unstructured":"Grier HE, Krailo MD, Tarbell NJ, et al: Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003, 348: 694-701. 10.1056\/NEJMoa020890.","journal-title":"N Engl J Med"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/archsurg.138.3.281","volume":"138","author":"RC Martin 2nd","year":"2003","unstructured":"Martin RC, Brennan MF: Adult soft tissue Ewing sarcoma or primitive neuroectodermal tumors: predictors of survival?. Arch Surg. 2003, 138: 281-285. 10.1001\/archsurg.138.3.281.","journal-title":"Arch Surg"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1200\/JCO.2003.10.033","volume":"21","author":"EA Kolb","year":"2003","unstructured":"Kolb EA, Kushner BH, Gorlick R, et al: Long-term event-free survival after intensive chemotherapy for Ewing's family of tumors in children and young adults. J Clin Oncol. 2003, 21: 3423-3430. 10.1200\/JCO.2003.10.033.","journal-title":"J Clin Oncol"},{"key":"15_CR9","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1200\/JCO.1993.11.10.1911","volume":"11","author":"ME Horowitz","year":"1993","unstructured":"Horowitz ME, Kinsella TJ, Wexler LH, et al: Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol. 1993, 11: 1911-1918.","journal-title":"J Clin Oncol"},{"key":"15_CR10","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.1993.11.8.1482","volume":"11","author":"S Burdach","year":"1993","unstructured":"Burdach S, Jurgens H, Peters C, et al: Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor prognosis Ewing's sarcoma. J Clin Oncol. 1993, 11: 1482-1488.","journal-title":"J Clin Oncol"},{"key":"15_CR11","first-page":"1697","volume":"16","author":"F Boulad","year":"1998","unstructured":"Boulad F, Kernan NA, LaQuaglia MP, et al: High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma. Clin Oncol. 1998, 16: 1697-1706.","journal-title":"Clin Oncol"},{"key":"15_CR12","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1200\/JCO.2000.18.21.3643","volume":"18","author":"JY Blay","year":"2000","unstructured":"Blay JY, Bouhour D, Ray-Coquard I, et al: High-dose chemotherapy with autologous hematopoietic stem-cell transplantation for advanced soft tissue sarcoma in adults. J Clin Oncol. 2000, 18: 3643-3650.","journal-title":"J Clin Oncol"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1023\/A:1026539908115","volume":"11","author":"S Burdach","year":"2000","unstructured":"Burdach S, van Kaick B, Laws HJ, et al: Allogeneic and autologous stem cell transplantation in advanced Ewing tumor: An update after long-term follow-up from two centers of the European Intergroup Study EICESS. Ann Oncol. 2000, 11: 1451-1462. 10.1023\/A:1026539908115.","journal-title":"Ann Oncol"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/(SICI)1096-911X(200005)34:5<328::AID-MPO3>3.0.CO;2-4","volume":"34","author":"D Hawkins","year":"2000","unstructured":"Hawkins D, Barnett T, Bensinger W, et al: Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-sarcoma-family tumors. Med Pediatr Oncol. 2000, 34: 328-337. 10.1002\/(SICI)1096-911X(200005)34:5<328::AID-MPO3>3.0.CO;2-4.","journal-title":"Med Pediatr Oncol"},{"key":"15_CR15","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1200\/JCO.2001.19.3.870","volume":"19","author":"BH Kushner","year":"2001","unstructured":"Kushner BH, Meyers PA: How effective is dose-intensive\/myeloablative therapy against Ewing's sarcoma\/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and literature review. J Clin Oncol. 2001, 19: 870-880.","journal-title":"J Clin Oncol"},{"key":"15_CR16","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1200\/JCO.2001.19.11.2812","volume":"19","author":"PA Meyers","year":"2001","unstructured":"Meyers PA, Krailo MD, Ladanyi M, et al: High-dose melphalan, etoposide, total body irradiation, and autologous stem cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol. 2001, 19: 2812-2820.","journal-title":"J Clin Oncol"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1200\/JCO.2002.08.081","volume":"20","author":"F Fagioli","year":"2001","unstructured":"Fagioli F, Aglietta M, Tienghi A, et al: High-dose chemotherapy in the treatment of relapsed osteosarcoma: an Italian sarcoma group study. J Clin Oncol. 2001, 20: 2150-2156. 10.1200\/JCO.2002.08.081.","journal-title":"J Clin Oncol"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/sj.bmt.1703023","volume":"27","author":"A Sauerbrey","year":"2001","unstructured":"Sauerbrey A, Bielack S, Kempf-Bielack B, et al: High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma. Bone Marrow Transplant. 2001, 27: 933-937. 10.1038\/sj.bmt.1703023.","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 5","key":"15_CR19","first-page":"S37","volume":"22","author":"R Miniero","year":"1998","unstructured":"Miniero R, Brach del Prever A, Vassallo E, et al: Feasibility of high-dose chemotherapy and autologous peripheral blood stem cell transplantation in children with high grade osteosarcoma. Bone Marrow Transplant. 1998, 22 (Suppl 5): S37-40.","journal-title":"Bone Marrow Transplant"},{"key":"15_CR20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1200\/JCO.1999.17.1.150","volume":"17","author":"M Van Glabbeke","year":"1999","unstructured":"Van Glabbeke M, van Oosterom AT, Oosterhuis JW, et al: Prognostic factors in advanced soft tissue sarcoma: an analysis of 2185 patients treated with anthracycline-containing first-line regimens \u2013 a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study. J Clin Oncol. 1999, 17: 150-157.","journal-title":"J Clin Oncol"},{"key":"15_CR21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.1993.11.7.1269","volume":"11","author":"JH Edmonson","year":"1993","unstructured":"Edmonson JH, Ryan LM, Blum RG, et al: Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol. 1993, 11: 1269-1275.","journal-title":"J Clin Oncol"},{"key":"15_CR22","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1200\/JCO.1993.11.7.1276","volume":"11","author":"KH Antman","year":"1993","unstructured":"Antman KH, Crowley J, Balcerzak SP, et al: An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol. 1993, 11: 1276-1285.","journal-title":"J Clin Oncol"},{"key":"15_CR23","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1200\/JCO.1995.13.7.1537","volume":"13","author":"A Santoro","year":"1995","unstructured":"Santoro A, Tursz T, Mouridsen H, et al: Doxorubicin versus CyVADic versus ifosfamide plus doxorubicin in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol. 1995, 13: 1537-1545.","journal-title":"J Clin Oncol"},{"key":"15_CR24","first-page":"517a","volume":"17","author":"NB Bui","year":"1998","unstructured":"Bui NB, Demaille MC, Chevreau C, et al: qMAID vs MAID+25% in adults with advanced soft tissue sarcoma (STS): first results of a randomized study of the FNCLCC Sarcoma Group. Proc Am Soc Clin Oncol. 1998, 17: 517a-(abstr 1991)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"15_CR25","first-page":"512a","volume":"17","author":"JY Blay","year":"1998","unstructured":"Blay JY, van Glabbeke M, Nielsen OS, et al: Five-year survivors in patients (pts) with advanced soft tissue sarcoma (ASTS) treated with doxorubicin: a study on 1742 patients (STBSG). Proc. 1998, 17: 512a-(abstr 1973)","journal-title":"Proc"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0959-8049(97)89006-5","volume":"33","author":"T Wiklund","year":"1997","unstructured":"Wiklund T, Saeter G, Strander H, et al: The Outcome of Advanced Soft Tissue Sarcoma Patients with Complete Tumour Regression after either Chemotherapy Alone or Chemotherapy plus Surgery. The Scandinavian Sarcoma Group Experience. Eur J Cancer. 1997, 33: 357-361. 10.1016\/S0959-8049(97)89006-5.","journal-title":"Eur J Cancer"},{"key":"15_CR27","first-page":"119","volume":"26","author":"C Seynaeve","year":"1999","unstructured":"Seynaeve C, Verweij J: High-dose chemotherapy in adult sarcomas: no standard yet. Semin Oncol. 1999, 26: 119-133.","journal-title":"Semin Oncol"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1357714031000114147","volume":"7","author":"JH Simon","year":"2003","unstructured":"Simon JH, Paulino AC, Ritchie JM, et al: Presentation, prognostic factors and patterns of failure in adult rhabdomyosarcoma. Sarcoma. 2003, 7: 1-7. 10.1080\/1357714031000114147.","journal-title":"Sarcoma"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1444-0903.2004.00630.x","volume":"34","author":"DS Ritchie","year":"2004","unstructured":"Ritchie DS, Grigg AP, Roberts AW, Rosenthal MA, Fox RM, Szer J: Staged autologous peripheral blood progenitor cell transplantation for Ewing sarcoma and rhabdomyosarcoma. Intern Med J. 2004, 34: 431-434. 10.1111\/j.1444-0903.2004.00630.x.","journal-title":"Intern Med J"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/sj.bmt.1704520","volume":"34","author":"B Kasper","year":"2004","unstructured":"Kasper B, Lehnert T, Bernd L, et al: High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas. Bone Marrow Transplant. 2004, 34: 37-41. 10.1038\/sj.bmt.1704520.","journal-title":"Bone Marrow Transplant"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0959-8049(01)00131-9","volume":"37","author":"CR Pinkerton","year":"2001","unstructured":"Pinkerton CR, Bataillard A, Guillo S, et al: Treatment strategies for metastatic Ewing's sarcoma. Eur J Cancer. 2001, 37: 1338-1344. 10.1016\/S0959-8049(01)00131-9.","journal-title":"Eur J Cancer"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1221::AID-CNCR4>3.0.CO;2-N","volume":"80","author":"C Bokemeyer","year":"1997","unstructured":"Bokemeyer C, Franzke A, Hartmann JT, et al: A phase I\/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas. Cancer. 1997, 80: 1221-1227. 10.1002\/(SICI)1097-0142(19971001)80:7<1221::AID-CNCR4>3.0.CO;2-N.","journal-title":"Cancer"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0959-8049(02)00480-X","volume":"39","author":"JY Blay","year":"2003","unstructured":"Blay JY, van Glabbekeb M, Verweijc J, et al: Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy. Eur J Cancer. 2003, 39: 64-69. 10.1016\/S0959-8049(02)00480-X.","journal-title":"Eur J Cancer"},{"key":"15_CR34","first-page":"273","volume":"30","author":"B Samuels","year":"1989","unstructured":"Samuels B, Elias A, Vogelzang N, et al: High dose chemotherapy with ABMT for refractory sarcoma. Proc Am Assoc Cancer Res. 1989, 30: 273-(abst 1086)","journal-title":"Proc Am Assoc Cancer Res"},{"key":"15_CR35","first-page":"405","volume":"10","author":"C Dumontet","year":"1992","unstructured":"Dumontet C, Biron P, Bouffet E, et al: High dose chemotherapy with ABMT in soft tissue sarcomas: a report of 22 cases. Bone Marrow Transplant. 1992, 10: 405-408.","journal-title":"Bone Marrow Transplant"},{"key":"15_CR36","doi-asserted-by":"crossref","first-page":"364a","DOI":"10.1200\/JCO.2001.19.2.364","volume":"19","author":"K Howson-Jan","year":"2001","unstructured":"Howson-Jan K, Hotte SJ, Tenhaaf D, et al: High dose chemotherapy (HDCT) and bone marrow transplant (BMT) in patients with advanced sarcoma: experience of a Canadian institution. Proc Am Soc Clin Oncol. 2001, 19: 364a-(abst1452)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"15_CR37","doi-asserted-by":"crossref","first-page":"821s","DOI":"10.1200\/jco.2004.22.90140.9014","volume":"22","author":"M Schlemmer","year":"2004","unstructured":"Schlemmer M, Wendtner CM, Falk M, et al: Efficacy of consolidation high-dose chemotherapy (HDCT) with ifosfamide, carboplatin and etoposide followed by peripheral blood stem cell rescue (PBSCR) in chemosensitive patients with metastatic soft tissue sarcomas. 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition). J Clin Oncol. 2004, 22: 821s-(abst 9014)","journal-title":"J Clin Oncol"}],"container-title":["International Seminars in Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7800-2-12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T19:47:14Z","timestamp":1630612034000},"score":1,"resource":{"primary":{"URL":"https:\/\/issoonline.biomedcentral.com\/articles\/10.1186\/1477-7800-2-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,31]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1186\/1477-7800-2-12","relation":{},"ISSN":["1477-7800"],"issn-type":[{"value":"1477-7800","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,31]]},"assertion":[{"value":"6 March 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}